🏛️ Verified NIH Record • Updated 2026-04-21
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease (NCT06773962)
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: TrueBinding, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
Who can join: Review the eligibility criteria below.
Location: Parkinson's Research Centers of America - Orange County — Aliso Viejo, California
Age range: 50 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- Parkinson's Research Centers of America - Orange County — Aliso Viejo, California
- Parkinson's Research Centers of America - Palo Alto — Palo Alto, California
- CenExel Rocky Mountain Clinical Research — Englewood, Colorado
- Parkinson's Disease and Movement Disorders Center of Boca Raton — Boca Raton, Florida
- University of Miami — Miami, Florida
- University of South Florida Parkinson's and Movement Disorders Center — Tampa, Florida
- Consultants in Neurology, Ltd — Northbrook, Illinois
- Josephson Wallack Munshower Neurology - Southeast — Indianapolis, Indiana
- University of Kansas Medical Center — Kansas City, Kansas
- Quest Research Institute — Farmington Hills, Michigan
- Parkinson's Research Centers of America - Long Island — Commack, New York
- NYU Langone Health — Patchogue, New York
- Oregon Health & Science University — Portland, Oregon
- Central Texas Neurology Consultants — Round Rock, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson's Disease (PD)
- IMPACT 360 for Parkinson's Disease — Vancouver, British Columbia
- Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease — Birmingham, Alabama
- AAV2-hAADC for Parkinson's Disease (PDCS-01) — Columbus, Ohio
- Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease — Stanford, California
- A Study of Buntanetap in Participants With PD — Birmingham, Alabama
Explore by condition: All Parkinson's Disease (PD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.